Zobrazeno 1 - 10
of 15
pro vyhledávání: ''
Autor:
Lucile L. Adams-Campbell, Julie R. Palmer, Mireille Bright-Gbebry, Kepher H. Makambi, Lynn Rosenberg, Adana A.M. Llanos, Joy Ann Phillips Rohan
Publikováno v:
BMC Complementary and Alternative Medicine
BMC Complementary and Alternative Medicine, Vol 11, Iss 1, p 30 (2011)
BMC Complementary and Alternative Medicine, Vol 11, Iss 1, p 30 (2011)
Background Complementary and alternative medicine (CAM) use, including herbals and multivitamin supplements, is quite common in the U.S., and has been shown to be highest in breast cancer survivors. However, limited data are currently available for C
Autor:
Neil Piller, Andrew Williams, Denis Visentin, Maarten A. Immink, Tony Barnett, Annette Loudon
Publikováno v:
BMC Complementary and Alternative Medicine
We aimed to evaluate the effect of an 8-week yoga intervention on the shoulder and spinal actions of women with breast cancer-related arm lymphoedema. A randomised controlled pilot trial. The intervention group (n = 12) completed eight weeks of daily
Publikováno v:
BMC Complementary and Alternative Medicine
Background Secondary arm lymphoedema continues to affect at least 20% of women after treatment for breast cancer requiring lifelong professional treatment and self-management. The holistic practice of yoga may offer benefits as an adjunct self-manage
Publikováno v:
BMC Complementary and Alternative Medicine
Background During the past few years, there has been an increasing interest among the Traditional and Folk medical practitioners of Sri Lanka in the use of a decoction prepared from Flueggea leucopyrus (Willd.) for treating various cancers including
Autor:
Aya Zarif, Dania Hariri, Zeina Nahleh, Mohamad Alameddine, Arafat Tfayli, Yasmin Aridi, Romy Abi Fadel, Maya Khalil, Anas Mugharbel, Farah Naja
Publikováno v:
BMC Complementary and Alternative Medicine
Background Breast cancer patients are increasingly seeking Complementary and Alternative Medicine (CAM) therapies with the hope of alleviating the burden of the disease and improving their quality of life (QOL). The objective of this study was to ass
Autor:
Flávia Aparecida Resende, Mariana Santoro de Camargo, Aline M. Prieto, Wagner Vilegas, José-Manuel Molina-Molina, Mariana F. Fernández, Osmany Cuesta-Rubio, Paula Karina Boldrin, Eliana Aparecida Varanda, Cássia Regina Primila Cardoso, Nicolás Olea
Publikováno v:
Scopus
Repositório Institucional da UNESP
Universidade Estadual Paulista (UNESP)
instacron:UNESP
BMC Complementary and Alternative Medicine
Digibug. Repositorio Institucional de la Universidad de Granada
instname
Repositório Institucional da UNESP
Universidade Estadual Paulista (UNESP)
instacron:UNESP
BMC Complementary and Alternative Medicine
Digibug. Repositorio Institucional de la Universidad de Granada
instname
Submitted by Vitor Silverio Rodrigues (vitorsrodrigues@reitoria.unesp.br) on 2014-05-27T11:30:04Z No. of bitstreams: 0Bitstream added on 2014-05-27T14:32:48Z : No. of bitstreams: 1 2-s2.0-84880934126.pdf: 413883 bytes, checksum: ddc1db78ebb0aa9c3cb6b
Autor:
Constance J. Temm, Victor Castillo, Shujie Cheng, Isaac Eliaz, Matt Welty, George E. Sandusky, Mark Alvarado, Daniel Sliva
Publikováno v:
BMC Complementary and Alternative Medicine
Background Tamoxifen (TAM) has been widely used for the treatment of estrogen receptor (ER)-positive breast cancer and its combination with other therapies is being actively investigated as a way to increase efficacy and decrease side effects. Here,
Autor:
Jar-Yi Ho, Shu Pin Chen, Cheng-Ping Yu, Ying Hsin Chen, Yao Chin Hsu, Ren Jun Hsu, Jui Ming Liu, Jyh Cherng Yu, Chia Lynn Fu, Fung Wei Chang
Publikováno v:
BMC Complementary and Alternative Medicine
Background Breast cancer-related mortality increases annually. The efficacy of current breast cancer treatments is limited, and they have numerous side effects and permit high recurrence. Patients with estrogen receptor (ER)-negative or triple-negati
Publikováno v:
BMC Complementary and Alternative Medicine
Women with metastatic breast cancer (MBC) have average life expectancies of about 2 years, and report high levels of disease-related symptoms including pain, fatigue, sleep disturbance, psychological distress, and functional impairment. There is grow
Publikováno v:
BMC Complementary and Alternative Medicine
Background z-Guggulsterone (z-Gug) and Gugulipid (GL) have been used to treat a variety of ailments. We now report their anti-cancer effect and mechanism against human breast cancer. Methods Using the human estrogen receptor-positive (MCF-7) and trip